Chemotherapy dose reduction and delay in clinical practice-Reference-Cited by-同舟云学术

Chemotherapy dose reduction and delay in clinical practice

Published:2000-04 Issue: Volume:36 Page:11-14
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Chang J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference14 articles.

1. Cancer statistics, 1997;Parker;CA Cancer J. Clin.,1997

2. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group;N. Engl. J. Med.,1988

3. Ovarian ablation in early breast cancer;Lancet,1996

4. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer;Gelber;Lancet,1996

5. The Steering Committee. Clinical practice guidelines for the care and treatment of breast cancer: a Canadian consensus document. Can Med Assoc J 1998, 158(Suppl).

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study;European Journal of Cancer;2024-10

2. The role of G-CSF in the prevention of cytostaticassociated adverse events during antitumor drug therapy;Meditsinskiy sovet = Medical Council;2024-07-25

3. Retrospective analysis of the effect of delayed chemotherapy on the prognosis of patients with stage III colorectal cancer receiving standard chemotherapy;2024-02-02

4. The Impact of Inter-Cycle Treatment Delays on 5-Year All-Cause Mortality in Early-Stage Breast Cancer;2024

5. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions;European Journal of Clinical Pharmacology;2023-12-15